Inventor
Bahram Resul
Inventor
Uppsala, SE
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes42%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07CAcyclic or carbocyclic compounds26%
C07DHeterocyclic compounds2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
PatentTitleYear
7,163,959'Prostagladin derivatives for the treatment of glaucoma or ocular hypertension'20076,562,868'Method for treatment of female sexual dysfunction'20036,495,563'Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula'20026,476,074'Method and composition for treatment of erectile dysfunction'20026,429,226'Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension'20026,417,230'Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension'20026,187,813'Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension'20016,030,999'Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension'20006,031,001'Use of prostaglandins'20005,849,791'Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension'19985,773,472'Method and means for prevention of cataract'19985,760,075'Method and means for prevention and treatment of secondary cataract'19985,627,208'Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension'19975,578,618'Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension'19965,516,796'Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof'19965,510,382'Method for composition for treatment of gastric and duodenal disorders'19965,422,368'Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension'19955,422,369'Prostaglanddin derivatives for the treatment of glaucoma or ocular hypertension'19955,359,095'Method for synthesis of prostaglandin derivatives'19945,321,128'Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension'19945,296,504'Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension'19945,223,537'Method and composition for treatment of gastric and duodenal disorders'19935,114,971'Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–1996Patents assigned to KABI PHARMACIA AB (6)· patent assignee history
1992–2007Based in Uppsala, SE· patent location history
1993–1998Based in Upsala, SE· patent location history
1994–2007Patents assigned to PHARMACIA AB (9)· patent assignee history
1994Patents assigned to KABI PHARMACIA (1)· patent assignee history
1998–2001Patents assigned to PHARMACIA & UPJOHN AB (3)· patent assignee history
2002–2003Patents assigned to SYNPHORA AB (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PHARMACIA AB | 9 | 1994–2007 |
| KABI PHARMACIA AB | 6 | 1992–1996 |
| PHARMACIA & UPJOHN AB | 3 | 1998–2001 |
| SYNPHORA AB | 3 | 2002–2003 |
| KABI PHARMACIA | 1 | 1994 |
Locations
| Location | Patents | Span |
|---|---|---|
| Uppsala, SE | 17 | 1992–2007 |
| Upsala, SE | 6 | 1993–1998 |